May 20, 2026 Combination Therapy Shows Potential in Psoriasis, Obesity Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis. Conexiant
May 20, 2026 Ivarmacitinib Eased Refractory PCA: Case Report Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report. Conexiant
May 14, 2026 Guselkumab Shows Psoriasis Benefit in Darker Skin Tones Randomized trial suggests sustained clearance across darker skin tones. Conexiant
May 14, 2026 Low-Dose Oral Minoxidil Monitoring Questioned A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months. Conexiant
May 13, 2026 AOPT Plus Collagen May Ease Rosacea Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks. Conexiant
May 13, 2026 AI Discharge Summaries Show Low Harm Risk Most reviewed summaries were rated as posing no harm risk, although omissions remained common. Conexiant
May 13, 2026 Medical Oddities: Ancient Practice Calms Modern BP Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide. Conexiant
May 08, 2026 Amputation Rates Rose in Opioid-Related Hospitalizations National inpatient analysis found steeper increases in amputations during opioid-related hospitalizations, particularly in the Northeast and West. Conexiant
May 07, 2026 Optimizing Nodal Staging for Early Metastasis Detection in cSCC Ultrasonography, CT may be superior, but have limited benefit in patients who are immunosuppressed. Conexiant
May 07, 2026 Tirzepatide's Surprising Skin Side Effect A single case report described possible lichen planus pigmentosus inversus following tirzepatide initiation. Conexiant